X-linked hyper IgM syndrome: Clinical, immunological and molecular features in patients from India

Blood Cells, Molecules, and Diseases

Volumn 53, Issue 3, 2014, Pages 99-104

  Madkaikar, Manisha ^a   Gupta, Maya ^a   Chavan, Sushant ^a   Italia, Khushnooma ^a   Desai, Mukesh ^b   Merchant, Rashid ^c   Radhakrishnan, Nita ^d   Ghosh, Kanjaksha ^a  

^a KEM HOSPITAL   (India)

^b B J WADIA HOSPITAL FOR CHILDREN   (India)

^c DR BALABHAI NANAVATI HOSPITAL   (India)

^d Ganga Ram Hospital   (India)

Author keywords

CD154; CD40L; CD40L gene; T cell and B cell immunodeficiency; X linked hyper IgM syndrome (XHIM)

Indexed keywords

CD40 LIGAND; GENOMIC DNA;

ARTICLE; CD4+ T LYMPHOCYTE; CD40L GENE; CHILD; CLINICAL ARTICLE; CLINICAL EVALUATION; CLINICAL FEATURE; CONTROLLED STUDY; DNA SEQUENCE; DNA SPLICING; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; HYPER IGM SYNDROME; INDIA; MISSENSE MUTATION; MOLECULAR MODEL; MUTATIONAL ANALYSIS; NONSENSE MUTATION; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; T LYMPHOCYTE ACTIVATION; X CHROMOSOME LINKED DISORDER; X LINKED HYPER IGM SYNDROME; CASE CONTROL STUDY; GENETICS; HYPER-IGM IMMUNODEFICIENCY SYNDROME, TYPE 1; IMMUNOLOGY; IMMUNOPHENOTYPING; INFANT; MALE; METABOLISM; MUTATION; NUCLEOTIDE SEQUENCE; PHENOTYPE; T LYMPHOCYTE SUBPOPULATION;

CASE-CONTROL STUDIES; CD40 LIGAND; CHILD; CHILD, PRESCHOOL; DNA MUTATIONAL ANALYSIS; GENE EXPRESSION; HUMANS; HYPER-IGM IMMUNODEFICIENCY SYNDROME, TYPE 1; IMMUNOPHENOTYPING; INDIA; INFANT; MALE; MUTATION; PHENOTYPE; T-LYMPHOCYTE SUBSETS;

EID: 84904720877     PISSN: 10799796     EISSN: 10960961     Source Type: Journal    
DOI: 10.1016/j.bcmd.2014.05.008     Document Type: Article

References (31)

1. Peron S., Metin A., Gardes P., Alyanakian M.A., Sheridan E., Kratz C.P., Fischer A., Durandy A. Human PMS2 deficiency is associated with impaired immunoglobulin class switch recombination. J. Exp. Med. 2008, 205:2465-2472.
2. Notarangelo L.D., Lanzi G., Peron S., Durandy A. Defects of class-switch recombination. J. Allergy Clin. Immunol. 2006, 117:855-864.
3. Davies E.G., Thrasher A.J. Update on the hyper immunoglobulin M syndromes. Br. J. Haematol. 2010, 149:167-180.
4. Allen R.C., Armitage R.J., Conley M.E., Rosenblatt H., Jenkins N.A., Copeland N.G., Bedell M.A., Edelhoff S., Disteche C.M., Simoneaux D.K., Fanslow W.C., Belmont J., Spriggs M.K. CD40 ligand gene defects responsible for X-linked hyper-IgM syndrome. Science 1993, 259:990-993.
5. Aruffo A., Farrington M., Hollenbaugh D., Li X., Milatovich A., Nonoyama S., Bajorath J., Grosmaire L.S., Stenkamp R., Neubauer M., Roberts R.L., Noelle R.J., Ledbetter J.A., Francke U., Ochs H.D. The CD40 ligand, gp39, is defective in activated T cells from patients with X-linked hyper-IgM syndrome. Cell 1993, 72:291-300.
6. Ferrari S., Giliani S., Insalaco A., Al-Ghonaium A., Soresina A.R., Loubser M., Avanzini M.A., Marconi M., Badolato R., Ugazio A.G., Levy Y., Catalan N., Durandy A., Tbakhi A., Notarangelo L.D., Plebani A. Mutations of CD40 gene cause an autosomal recessive form of immunodeficiency with hyper IgM. Proc. Natl. Acad. Sci. U. S. A. 2001, 98:12614-12619.
7. Lougaris V., Badolato R., Ferrari S., Plebani A. Hyper immunoglobulin M syndrome due to CD40 deficiency: clinical, molecular, and immunological features. Immunol. Rev. 2005, 203:48-66.
8. Hollenbaugh D., Grosmaire L.S., Kullas C.D., Braesch-Andersen S., Noelle R.J., Stamenkovic I., Ledbetter J.A., Aruffo A. The human T cell antigen gp39, a member of the TNF gene family, is a ligand for the CD40 receptor: expression of a soluble form of gp39 with B cell co-stimulatory activity. EMBO J. 1992, 11:4313-4321.
9. Winkelstein J.A., Marino M.C., Ochs H., Fuleihan R., Scholl P.R., Geha R., Stiehm E.R., Conley M.E. The X-linked hyper-IgM syndrome: clinical and immunologic features of 79 patients. Medicine 2003, 82:373-384.
10. Hayward A.R., Levy J., Facchetti F., Notarangelo L., Ochs H.D., Etzioni A., Bonnefoy J.Y., Cosyns M., Weinberg A. Cholangiopathy and tumors of the pancreas, liver, and biliary tree in boys with X-linked immunodeficiency with hyper-IgM. J. Immunol. 1997, 158:977-983.
11. Levy J., Espanol-Boren T., Thomas C., Fischer A., Tovo P., Bordigoni P. Clinical spectrum of X-linked hyper-IgM syndrome. J. Pediatr. 1997, 131:47-54.
12. Ochs H.D., Smith C.I. X-linked agammaglobulinemia: a clinical and molecular analysis. Medicine 1996, 75:287-299.
13. Gennery A.R., Khawaja K., Veys P., Bredius R.G., Notarangelo L.D., Mazzolari E., Fischer A., Landais P., Cavazzana-Calvo M., Friedrich W., Fasth A., Wulffraat N.M., Matthes-Martin S., Bensoussan D., Bordigoni P., Lange A., Pagliuca A., Andolina M., Cant A.J., Davies E.G. Treatment of CD40 ligand deficiency by hematopoietic stem cell transplantation: a survey of the European experience, 1993-2002. Blood 2004, 103:1152-1157.
14. O'Gorman M.R., Zaas D., Paniagua M., Corrochano V., Scholl P.R., Pachman L.M. Development of a rapid whole blood flow cytometry procedure for the diagnosis of X-linked hyper-IgM syndrome patients and carriers. Clin. Immunol. Immunopathol. 1997, 85:172-181.
15. Rapid PID. http://rapid.rcai.riken.jp.
16. Pertea M., Lin X., Salzberg S.L. GeneSplicer: a new computational method for splice site prediction. Nucleic Acids Res. 2001, 29:1185-1190.
17. Desmet F.O., Hamroun D., Lalande M., Collod-Béroud G., Claustres M., Béroud C. Human Splicing Finder: an online bioinformatics tool to predict splicing signals. Nucleic Acids Res. 2009, 37(e67):1-14.
18. Choi Y., Gregory Simsa E., Murphyb S., Miller J.R., Agnes P. Predicting the functional effect of amino acid substitutions and indels 2012, 10:1-13.
19. Quartier P., Bustamante J., Sanal O., Plebani A., Debré M., Deville A., Litzman J., Levy J., Fermand J.P., Lane P., Horneff G., Aksu G., Yalçin I., Davies G., Tezcan I., Ersoy F., Catalan N., Imai K., Fischer A., Durandy A. Clinical, immunologic and genetic analysis of 29 patients with autosomal recessive hyper-IgM syndrome due to activation-induced cytidine deaminase deficiency. Clin. Immunol. 2004, 110:22-29.
20. Imai K., Slupphaug G., Lee W.I., Revy P., Nonoyama S., Catalan N., Yel L., Forveille M., Kavli B., Krokan H.E., Ochs H.D., Fischer A., Durandy A. Human uracil-DNA glycosylase deficiency associated with profoundly impaired immunoglobulin class-switch recombination. Nat. Immunol. 2003, 10:1023-1028.
21. Mavroudi I., Papadaki V., Pyrovolaki K., Katonis P., Eliopoulos A.G., Papadaki H.A. The CD40/CD40 ligand interactions exert pleiotropic effects on bone marrow granulopoiesis. J. Leukoc. Biol. 2011, 89:771-783.
22. Wang W.C., Cordoba J., Infante A.J., Conley M.E. Successful treatment of neutropenia in the hyper-immunoglobulin M syndrome with granulocyte colony-stimulating factor. J. Pediatr. Hematol. Oncol. 1994, 16:160-163.
23. Mori M., Nonoyama S., Neubauer M., Mitsuda T., Kosuge T., Yokota S. Mutation analysis and therapeutic response to granulocyte colony-stimulating factor in a case of hyperimmunoglobulin M syndrome with chronic neutropenia. J. Pediatr. Hematol. Oncol. 2000, 22:288-289.
24. Gilmour K.C., Walshe D., Heath S., Monaghan G., Loughlin S., Lester T., Norbury G., Cale C.M. Immunological and genetic analysis of 65 patients with a clinical suspicion of X linked hyper-IgM. Mol. Pathol. 2003, 56:256-262.
25. Nonoyama S., Penix L.A., Edwards C.P. Diminished expression of CD40 ligand by activated neonatal cells. J. Clin. Invest. 1995, 95:66-75.
26. Lee W.I., Torgerson T.R., Schumacher M.J., Yel L., Zhu Q., Ochs H.D. Molecular analysis of a large cohort of patients with hyper immunoglobulin M (IgM) syndrome. Blood 2005, 105:1881-1890.
27. Shimadzu M., Nunoi H., Terasaki H. Structural organization of the gene for CD40 ligand: molecular analysis for diagnosis of X-linked hyper-IgM syndrome. Biochim. Biophys. Acta 1995, 72:1260-1267.
28. Thusberg J., Vihinen M. The structural basis of hyper IgM deficiency - CD40L mutations. Protein Eng. Des. Sel. 2007, 3:133-141.
29. Van Hoeyveld E., Zhang P.X., De Boeck K., Fuleihan R., Bossuyt X. Hyper-immunoglobulin M syndrome caused by a mutation in the promotor for CD40L. Immunology 2007, 120:497-501.
30. Seyama K., Nonoyama S., Gangsaas I., Hollenbaugh D., Pabst H.F., Aruffo A., Ochs H.D. Mutations of the CD40 ligand gene and its effect on CD40 ligand expression in patients with X-linked hyper IgM syndrome. Blood. 1998, 92:2421-2434.
31. Find Lewis E.M., Singla M., Sergeant S., Koty P.P., McPhail L.C. X-linked chronic granulomatous disease secondary to skewed X chromosome inactivation in a female with a novel CYBB mutation and late presentation. Clin. Immunol. 2008, 129:372-380.